GPT and fatty liver disease: Importantly, our study showed that DHCR24 inhibition by SH42 not only prevented but also affected NASH progression in mice with established hepatic steatosis, as evidenced by reducing the number of hepatic crown‐like structures, collagen content, and plasma alanine transaminase levels.